InCurA raises pre-Seed round to fuel expansion plans

Tiye Angels, Egypt's first female angel investment network, celebrates its first investment in InCurA, a medical device company. This marks a milestone for Tiye Angels and demonstrates their commitment to Gender Lens Investing (GLI) and supporting female founders.

InCurA, led by CEO Wessam Sarhan and CTO Moussa Salem ElSayed, focuses on creating innovative medical devices with scalable manufacturing capabilities. Their hemostatic agents, ColiSorB and CurASeal, offer enhanced efficacy compared to existing products, addressing a critical need in the market.

Tiye Angels' investment not only provides capital but also aligns with InCurA's mission to democratize access to healthcare. The terms of the investment were not disclosed.